Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
12.36B | 9.91B | 10.39B | 9.65B | 8.77B | Gross Profit |
12.36B | 9.91B | 10.39B | 9.65B | 8.77B | EBIT |
5.10B | 3.44B | 5.92B | 182.00M | -2.61B | EBITDA |
0.00 | 0.00 | 0.00 | 974.00M | 0.00 | Net Income Common Stockholders |
2.68B | 2.22B | 1.44B | 430.00M | -2.89B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
79.12B | 65.82B | 86.65B | 60.21B | 81.21B | Total Assets |
565.99B | 517.17B | 477.44B | 473.04B | 506.92B | Total Debt |
0.00 | 109.23B | 43.77B | 43.84B | 46.12B | Net Debt |
-79.12B | -102.69B | -42.88B | -16.36B | -35.09B | Total Liabilities |
518.93B | 484.16B | 43.77B | 43.84B | 46.12B | Stockholders Equity |
34.47B | 31.99B | 30.02B | 28.85B | 27.48B |
Cash Flow | Free Cash Flow | |||
-21.46B | 19.09B | 25.18B | -25.23B | 32.78B | Operating Cash Flow |
-20.32B | 20.09B | 25.86B | -24.26B | 33.68B | Investing Cash Flow |
-1.31B | -920.00M | -713.00M | -804.00M | -1.22B | Financing Cash Flow |
565.00M | -1.09B | 178.00M | -1.21B | 2.21B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | €33.17B | 11.92 | 9.28% | 2.32% | 17.06% | 25.66% | |
64 Neutral | $12.85B | 9.81 | 7.59% | 16985.65% | 12.30% | -7.71% | |
$54.83B | 11.53 | 6.68% | 2.58% | ― | ― | ||
71 Outperform | €579.56M | 6.04 | 9.17% | 6.65% | 11.25% | -8.00% | |
€188.41M | 27.13 | 2.68% | ― | ― | |||
€183.47M | ― | ― | ― | ― | |||
€121.35M | 10.15 | 3.21% | ― | ― |